Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

ConclusionsCompared with enalapril, sacubitril/valsartan led to a slower rate of decrease in the eGFR and improved cardiovascular outcomes, even in patients with chronic kidney disease, despite causing a modest increase in UACR.Graphical abstract
Source: JACC: Heart Failure - Category: Cardiology Source Type: research